Testosterone Cypionate Injections

Physician-led TRT education

Testosterone Cypionate Injections for TRT

Testosterone cypionate is a long-acting injectable testosterone ester commonly used to treat appropriately diagnosed male hypogonadism. Dose and frequency should be individualized from symptoms, laboratory results, response and adverse effects.

Medically reviewed by Dr. Timothy Mackey
Medical Director · Reviewed and approved September 10, 2026

What is testosterone cypionate?

Testosterone cypionate is testosterone attached to the cypionate ester, which slows release after injection. Once released and metabolized, the active hormone is testosterone. The ester primarily changes pharmacokinetics; it does not make the testosterone molecule inherently more “natural” or more “bioidentical” than other testosterone preparations.

For a broader overview, see our testosterone replacement therapy guide.

Cypionate versus other testosterone formulations

Compare practical needs with the physician: self-injection comfort, skin contact with family, cost, ability to adjust treatment and adverse effects. These are formulation comparisons, not a list of treatments available at NovaGenix. See Endocrine Society patient information and gel transfer precautions.

What is testosterone cypionate approved to treat?

FDA labeling includes replacement therapy in males with primary hypogonadism and hypogonadotropic hypogonadism caused by specified congenital or acquired conditions. A clinician should establish the diagnosis before treatment and investigate potentially reversible causes when appropriate.

Age-related symptoms alone do not establish hypogonadism. Testosterone testing, symptoms, medications, sleep, weight, pituitary/testicular function and other health factors may all be relevant.

How is testosterone cypionate given?

Intramuscular (IM): Standard FDA-approved testosterone cypionate labeling specifies injection into muscle. Use the route and technique taught for your exact prescription.

Subcutaneous (under the skin): Some clinicians prescribe cypionate by this route off-label. Small studies support absorption and acceptable tolerability, but they do not establish that subcutaneous cypionate is universally safer or better. A small cypionate study involved 11 transgender patients, so its findings should not be treated as a large trial in men with hypogonadism.

Do not switch routes, needle sizes or injection sites without training from the prescribing team. An approved subcutaneous enanthate product does not make subcutaneous use of every testosterone vial FDA-approved.

See our testosterone injection safety guide.

How often is testosterone cypionate injected?

There is no single schedule that is ideal for every patient. FDA labeling permits dosing intervals that differ from many contemporary TRT practices, while clinicians may use smaller, more frequent doses to manage symptoms, peaks, troughs and adverse effects. The correct regimen depends on the individual patient and achieved testosterone concentrations.

Patients should not copy another person's weekly dose or change frequency without discussing it with the prescriber. See our guide to testosterone dosing.

Peaks, troughs and when to draw blood

A peak is a higher concentration after an injection; a trough is the lower concentration before the next dose. Cypionate levels rise and fall across an interval. A small pharmacokinetic study documented substantial fluctuations with a two-week regimen; that does not predict every patient's pattern.

Symptoms that recur before the next injection are useful to report, but they do not prove that the dose is too low. Record the injection date, dose, symptoms and blood-draw time so the clinician can interpret them together.

Cypionate versus enanthate

Testosterone cypionate and testosterone enanthate are both long-acting injectable esters used for testosterone replacement. Their pharmacokinetic differences are relatively modest, and one is not universally “better.” Availability, formulation, carrier oil, tolerability, dosing strategy and patient response can influence the choice.

Read the detailed comparison: testosterone cypionate vs. enanthate.

What benefits can TRT provide?

In appropriately diagnosed men, testosterone replacement can improve symptoms related to androgen deficiency. Potential benefits may involve sexual symptoms, body composition, anemia, bone density or other domains depending on the patient's baseline condition. Response varies, and treatment should be continued because benefits outweigh risks for that individual—not merely to chase a laboratory target.

What might patients notice—and how soon?

Blood levels change before every symptom can be meaningfully reassessed. Sexual interest may improve over the first several weeks, while body-composition and bone effects are assessed over months or longer. There is no guaranteed first-week response or fixed amount of muscle gain.

In the Testosterone Trials, older men using testosterone gel had improved sexual function but no significant benefit on the primary vitality measure. This supports realistic expectations for TRT; it is not proof of an identical cypionate-specific result.

If appropriate testosterone levels do not bring meaningful benefit, the next step is to reassess sleep, mood, medications, other causes of symptoms and whether to continue treatment. Automatically increasing the dose can increase exposure without solving the problem.

What are the important risks and side effects?

Potential adverse effects include acne or oily skin, edema, gynecomastia, changes in mood or libido, suppression of sperm production, testicular atrophy and increased hemoglobin/hematocrit. Injection-site reactions can also occur.

Testosterone products carry labeling related to blood pressure and other risks, and treatment requires individualized assessment. Patients should promptly report concerning symptoms and attend scheduled monitoring.

Testosterone cypionate and hematocrit

Injectable testosterone can raise hemoglobin and hematocrit. The AUA recommends baseline measurement and intervention when hematocrit reaches 54% or higher during therapy. Persistently elevated hematocrit should trigger review of testosterone exposure and other causes rather than automatic indefinite blood donation.

Read our detailed guide to high hematocrit on TRT.

Estradiol, breast symptoms and fluid retention

Some testosterone is converted to estradiol. Breast tenderness, enlargement or swelling should prompt assessment, rather than assuming every symptom is “high estrogen.” The clinician may check estradiol when indicated and review the testosterone regimen. An estrogen blocker is not an automatic companion to TRT. See the AUA guidance on estradiol evaluation.

Blood pressure, cardiovascular health and prostate monitoring

Testosterone can raise blood pressure. The FDA's 2025 labeling action removed boxed-warning language about increased major cardiovascular outcomes following TRAVERSE, while requiring blood-pressure warnings. TRAVERSE studied testosterone gel; it was not a direct safety trial of every cypionate regimen.

FDA requested further labeling updates in June 2026, including changes to age-related limitation-of-use language and prostate/BPH safety information. These changes do not eliminate the need for an accurate diagnosis or individual risk assessment.

Review blood pressure, cardiovascular history and urinary symptoms before and during care. PSA assessment depends on age, risk and shared decision-making; a concerning PSA change or examination requires evaluation rather than an assumption that TRT caused cancer. Previous prostate cancer warrants specialist discussion.

Read our TRT and blood-pressure guide.

When treatment should wait or needs additional evaluation

Examples include elevated hematocrit, untreated severe sleep apnea, uncontrolled heart failure, recent heart attack or stroke, thrombophilia, concerning prostate findings or current fertility plans. The Endocrine Society guideline outlines these situations.

The specific cypionate label reviewed here also lists drug hypersensitivity, male breast cancer, known or suspected prostate cancer, and serious cardiac, liver or kidney disease among contraindications. The prescriber should check the current label for the dispensed product in light of FDA updates, including carrier-oil or ingredient allergies.

What about fertility?

Exogenous testosterone suppresses LH and FSH and can substantially reduce sperm production. Men who want current or future fertility should discuss this before starting TRT. The 2024 AUA/ASRM guideline advises against prescribing exogenous testosterone for men interested in current or future fertility. Evidence is too limited to recommend adding hCG or other medications to ongoing TRT as a reliable fertility-preservation strategy.

See our TRT and fertility guide and information about hCG therapy.

Testicular size may decrease during treatment. A normal blood testosterone level does not establish normal sperm production. Suppression is not reliable contraception, and recovery after stopping varies. Discuss semen testing or sperm banking before treatment when relevant; referral to a reproductive specialist may be appropriate.

What monitoring is needed?

The Endocrine Society monitoring guidance informs the schedule; it is adjusted to risk and response. Do not wait for a routine appointment when concerning symptoms develop.

Prepare with our testosterone testing in Palm Beach County guide.

Injection safety at home

• Confirm the medication, concentration, prescribed amount in mg and corresponding volume in mL. They are different units.
• Wash hands, use a clean preparation area and use a new sterile needle and syringe for every injection. Never share equipment or re-enter a vial with used equipment.
• Use only the demonstrated route and sites. Follow the pharmacy's storage, expiration and vial-discard instructions.
• Place used sharps directly into a suitable sharps container. Ask the team to review technique if you are unsure.

These principles follow CDC injection-safety guidance. Increasing redness, warmth, drainage, fever or significant injection-site pain needs medical attention.

Frequently asked questions

Is testosterone cypionate a steroid?

It is an androgen and anabolic steroid medication, but medically prescribed testosterone replacement is different from nonmedical anabolic-steroid use. The clinical objective is replacement in appropriately diagnosed deficiency.

Is testosterone cypionate bioidentical?

After the ester is cleaved, the active hormone is testosterone. “Bioidentical” is not a marker of FDA approval, safety or product quality, and the term should not be used to imply that one ester is inherently safer than another.

How long does testosterone cypionate stay in the body?

It is a long-acting ester with effects that persist beyond the day of injection. Exact pharmacokinetics vary by dose, formulation and individual physiology, so dosing should be guided clinically rather than by a single internet half-life number.

Can testosterone cypionate cause infertility?

It can suppress sperm production, sometimes severely. Fertility goals should be discussed before treatment, and men actively trying to conceive generally need a different strategy.

Can I inject testosterone cypionate subcutaneously?

Subcutaneous use of standard cypionate is off-label. It may be prescribed for selected patients, but use only the route and technique specified by your clinician.

Is a weekly injection better than every two weeks?

Neither interval is right for everyone. The prescriber considers exposure, symptoms across the interval, timed labs and adverse effects. Changing frequency also requires checking the total prescribed amount.

What if I miss an injection?

Contact the prescribing team or pharmacist for instructions. Do not double a dose or improvise a catch-up schedule.

When should I have my testosterone checked?

Use the timing requested by your clinician relative to your injection, and report the last dose and blood-draw date. Consistent timing helps make successive results interpretable.

Do I need an estrogen blocker?

Not automatically. Breast symptoms or other concerns deserve assessment; do not add medication based only on an internet target for estradiol.

Medical sources

• DailyMed: Testosterone Cypionate Injection labeling
• American Urological Association: Testosterone Deficiency Guideline
• Endocrine Society: Testosterone Therapy in Men With Hypogonadism

This article is educational and does not replace individualized medical advice, diagnosis or prescription instructions.